Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Pharmacological and Toxicological Methods|July 22, 2018
In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practicesJean-Pierre Valentin, Jean-Michel Guillon, Stephen Jenkinson, et al.Ebiomedicine|June 23, 2020
Machine learning guided association of adverse drug reactions with in vitro target-based pharmacologyRobert Ietswaart, Seda Arat, Amanda X Chen, et al.Journal of Molecular and Cellular Cardiology|September 21, 2013
Preservation of cardiomyocytes from the adult heartNajah Abi-Gerges, Amy Pointon, Georgia F Pullen, et al.Toxicology and Applied Pharmacology|October 22, 2024
In vitro pharmacologic profiling aids systemic toxicity assessment of chemicalsMatthew Burbank, Predrag Kukic, Gladys Ouedraogo, et al.Endocrinology|December 31, 2005
Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3John W M Creemers, Lynn E Pritchard, Amy Gyte, et al.Nature Reviews. Drug Discovery|May 21, 2024
The state of the art in secondary pharmacology and its impact on the safety of new medicinesRichard J Brennan, Stephen Jenkinson, Andrew Brown, et al.Science (New York, N.Y.)|July 25, 2020
The activities of drug inactive ingredients on biological targetsJoshua Pottel, Duncan Armstrong, Ling Zou, et al.Journal of Medicinal Chemistry|April 30, 2021
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive BacteriaGuillaume Lapointe, Colin K Skepper, Lauren M Holder, et al.Journal of Medicinal Chemistry|July 8, 2020
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative BacteriaColin K Skepper, Duncan Armstrong, Carl J Balibar, et al.Pageof 2